Log In
Print this Print this

IGF-methotrexate conjugate

  Manage Alerts
Collapse Summary General Information
Company IGF Oncology LLC
DescriptionCovalent conjugate of methotrexate coupled to an engineered variant of insulin-like growth factor-1 (IGF-1)
Molecular Target Insulin-like growth factor-1 (IGF-1) receptor (IGF1R) (CD221)
Mechanism of ActionDNA synthesis inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today